FOR IMMEDIATE RELEASE SALT LAKE CITY, July 27, 2023 – Proposed expansions of federal government-mandated drug pricing policies present serious consequences for the development of and investment in new medicines, and significant job losses in major innovation hubs such as Utah,...

Edmonton, Alberta, Canada/April 10, 2023- Pacylex Pharmaceuticals today announced it will be presenting at two exclusive life science startup events in Canada in April, spotlighting its emergence as one of the premier Canadian biotech startup companies. Pacylex is focused on i...

Salt Lake City- March, 21, 2023 - BioUtah today applauds nView Medical and Birch OS, the winner and runner up, respectively, of the Pitch Competition held March 16 during the 2023 Wilson Sonsini Entrepreneur & Investor Life Sciences Summit (E&I Summit). The E&I Summit, present...

Chicago, IL/Salt Lake City- March 9, 2023- Content Carnivores, a digital marketing agency, is honored to be a Premier Sponsor at the 2023 Wilson Sonsini Entrepreneur and Investor Life Sciences Summit.  Content Carnivores is also pleased to be part of creating and presenting at...

Salt Lake City, March 9 - BioUtah, Utah’s only trade association dedicated solely to the life sciences, in partnership with the University of Utah’s Partners for Innovation, Ventures, Outreach & Technology (PIVOT) Center, today announced the six Utah life sciences startup comp...

Salt Lake City - January 24 - BioUtah, Utah’s trade association dedicated to the life sciences, in partnership with the University of Utah’s Partners for Innovation, Ventures, Outreach & Technology (PIVOT) Center and BioHive today announced its distinguished keynote speaker, J...

Gisela joined Oncocyte in October 2021 as the firm’s Chief Operating Officer and was promoted to President and Chief Operating Officer in August 2022. She brings a wealth of knowledge and first-hand experience, leading large-scale operations at global pharmaceutical and diagno...

Boston, MA – September 16, 2022 – Reportable launched a new Life Science Intelligence software for biopharma, diagnostics and medical device companies to seamlessly track business developments and scientific advancements. Custom briefs consolidate multiple disparate informatio...

With U.S. Biotech companies currently on track for a 75% reduction in going public this year compared to 2021, Intensity remains committed to waiting until market conditions improve while maintaining an active S-1 on file with the SEC. To weather the storm, a private "cross-ov...

Please join VCapital and two of their outstanding portfolio companies on Tuesday, June 28. You will meet the leaders of SentiAR and EDJX, with an opportunity to ask questions about their companies, their progress, and the exciting categories of Augmented Reality and Edge Compu...